Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAVOUR: Vedolizumab faecal loss in ulcerative colitis
NCT04006080Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Jul 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
A Phase 4 trial of vedolizumab in ulcerative colitis (UC), sponsored by Guy's and St Thomas' NHS Foundation Trust. Status: unknown.
02
Drugs
vedolizumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04006080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006080.